Sanofi invests 170 million euros in French vaccines facility

PARIS (Reuters) – Sanofi will invest 170 million euros ($202 million) to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a drive aimed at boosting the production of one of its influenza vaccines.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply